Management and Prevention of Propofol Infusion Syndrome

Clinical Features and Diagnosis

• Propofol infusion syndrome (PRIS) presents with worsening metabolic acidosis, hypertriglyceridemia, hypotension with increasing vasopressor requirements, cardiac arrhythmias, acute kidney injury, hyperkalemia, rhabdomyolysis, and liver dysfunction in critically ill patients receiving propofol infusions 1, 2

Risk Factors

• Prolonged administration of high propofol doses (>70 μg/kg/min) is a key risk factor for developing PRIS, though it can occur with lower doses 1, 2

Prevention Strategies

• The American College of Critical Care Medicine recommends limiting propofol infusion rates and avoiding prolonged infusions (>48 hours) when possible, although specific dosing considerations are not provided in the cited references 1, 2
• Daily laboratory monitoring, including serum triglycerides, arterial blood gases, renal and liver function tests, is crucial for early detection of PRIS 1, 2
• Consider alternative sedatives such as dexmedetomidine for patients with acute neurological illnesses or inflammatory conditions 1, 2

Management of Established PRIS

• Discontinue propofol infusion immediately upon suspicion of PRIS and provide supportive care focused on organ dysfunction 1, 2
• Management of metabolic acidosis and renal replacement therapy for acute kidney injury are essential supportive measures 1, 2

Clinical Pitfalls and Caveats

• PRIS can be difficult to diagnose due to its variable presentation and overlap with common ICU complications, with a mortality rate of up to 33% 1, 2
• The incidence of PRIS with propofol infusions is approximately 1%, and early signs such as unexplained metabolic acidosis should prompt immediate evaluation 1, 2

Alternative Sedation Strategies

• Dexmedetomidine has minimal respiratory depression and a different mechanism of action, making it a suitable alternative for patients requiring long-term sedation 1, 2
• Benzodiazepines can be used, but monitoring for propylene glycol toxicity with lorazepam is necessary 1, 3

Propofol Infusion Syndrome Prevention and Management

Alternative Sedation Strategies

• The European Heart Journal recommends considering dexmedetomidine or benzodiazepines, such as midazolam, for sedation beyond 48 hours, as they may be safer for prolonged sedation than high-dose propofol 4
• An analgesic-first approach using low-dose fentanyl infusion with minimal sedative added is also a viable option for long-term sedation 4

Practical Recommendation for ICU Sedation

• The European Heart Journal suggests maintaining propofol at 5-50 μg/kg/min and reassessing daily whether continuation is necessary, and considering transitioning to dexmedetomidine or an analgesic-first strategy with minimal sedation after 48 hours 4

Management and Prevention of Propofol Infusion Syndrome

Prevention Strategies

• The American College of Critical Care Medicine recommends maintaining propofol infusion rates <70 μg/kg/min (ideally 5-50 μg/kg/min) to prevent PRIS 5
• The American College of Critical Care Medicine suggests switching to dexmedetomidine (0.2-0.7 μg/kg/hr) or midazolam-based sedation after 48 hours of propofol use to avoid PRIS risk 5
• Dexmedetomidine can be loaded with 1 μg/kg over 10 minutes and maintained at 0.2-1.5 μg/kg/hr as tolerated, with monitoring for bradycardia and hypotension 5
• Midazolam can be used as an alternative sedation strategy, loaded with 0.01-0.05 mg/kg and maintained at 0.02-0.1 mg/kg/hr 5
• Lorazepam can also be used, loaded with 0.02-0.04 mg/kg and maintained at 0.01-0.1 mg/kg/hr, with monitoring for propylene glycol toxicity 5

Propofol Infusion Dose for Adult ICU Patients

Initial Dosing Strategy

• The American College of Critical Care Medicine recommends starting propofol at 5 μg/kg/min without a loading bolus in hemodynamically unstable patients 6, 7
• A loading dose of 5 μg/kg/min over 5 minutes may be administered only in hemodynamically stable patients 6, 7

Maintenance Infusion Rates

• The standard maintenance range for most adult ICU patients is 5-50 μg/kg/min, with a recommendation to target lighter sedation levels to improve outcomes 6, 7

Time-Based Decision Algorithm

• The Society of Critical Care Medicine suggests switching to dexmedetomidine after 48 hours of continuous propofol infusion to minimize PRIS risk, with a loading dose of 1 μg/kg over 10 minutes and a maintenance dose of 0.2-0.7 μg/kg/hr 6, 7
• Alternatively, transitioning to midazolam 0.02-0.1 mg/kg/hr after loading with 0.01-0.05 mg/kg is recommended 6, 7

Propofol Sedation in Adult ICU Patients

Introduction to Sedation Guidelines

• The Society of Critical Care Medicine recommends propofol or dexmedetomidine over benzodiazepines for mechanically ventilated adults, as both agents reduce time to extubation and delirium incidence compared to benzodiazepines 8, 9
• Dexmedetomidine is preferred over propofol for sedation in adult ICU patients when deep sedation or neuromuscular blockade is not required, with a contraindication for use when deep sedation or neuromuscular blockade is necessary 8, 9

Sedation Management

• The American College of Critical Care Medicine suggests that propofol and dexmedetomidine have similar effects on time to extubation, but dexmedetomidine reduces delirium at 48 hours post-sedation cessation and improves patient communication 8, 9
• Guidelines explicitly recommend against using propofol for sleep promotion due to REM suppression and lack of benefit 10